CDK2-IN-41
Product Specifications
Target
Apoptosis, Reactive Oxygen Species, ROS, CDK
Related Pathways
Apoptosis, Immunology/Inflammation, NF-κB, Cell Cycle/Checkpoint, Metabolism
Bioactivity
CDK2-IN-41 (Compound 7a) is a CDK2 inhibitor that impedes the cell cycle by binding to CDK2, leading to cytotoxicity, increased ROS production, and apoptosis (Apoptosis) . It exhibits anticancer activity with an IC50 of 10 μM against acute myeloid leukemia (AML) HL-60 cells. CDK2-IN-41 is applicable in research related to AML-associated cancers.
Molecular Formula
C19H21N3S
Molecular Weight
323.46
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-13318R-APC-Cy7 100 µL
GCNT6 Polyclonal Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details